Ivím Health

Ivím Health: Telemedicine for Weight Loss and Hormone Health

Ivím Health is an American virtual healthcare company that structures its services around individualized programs for weight loss, women's and men's hormone health, and general wellness. Its model combines medical prescribing, continuous monitoring, and a team of certified providers, with unlimited visits and direct access to professionals.

Weight Loss Programs

The company offers treatments with GLP-1 medications, both in compounded and brand-name formulations. The catalog includes compounded versions of tirzepatide and semaglutide, with six-month plans that the website presented at a monthly price of $133 and $75 respectively. Brand-name options such as Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda, and liraglutide are also listed, along with an oral presentation of Wegovy that the site describes as the first FDA-approved oral GLP-1. The company states that these medications are dispensed by prescription only and for active members of the weight loss program.

Hormone Health and Whole-Body Wellness

Ivím Health extends its offering to women's and men's hormone health. It complements these programs with supplements classified by area: energy and metabolism (NAD+, B12, lipotropics, multivitamins, vitamin D3+K2, greens+, berberine, fiber), sleep and stress (sermorelin, magnesium+ glycine), body composition (protein powder, creatine, amino acids+), immunity and repair (colostrum complex, Akkermansia+, electrolyte blend), hepatic health, longevity and skin (collagen+, krill, Renu with NMN, copper hair spray, and copper skin cream). The company announces upcoming peptide therapies, for which it maintains a waitlist.

Care Model and Membership

Ivím Health's approach relies on assigning a certified provider to each member, with unlimited visits and flexible scheduling. The company states that each patient is matched with a physician who knows their history and adjusts the plan according to results. The membership includes access to functional health coaches, a patient experience team, and a 20% discount on supplements. The site mentions a price of $75 per month with the first month free, although this is promotional information subject to change.

Published Results and Recognition

Ivím Health notes that its clinical results have been published in the peer-reviewed journal Obesity Pillars, in retrospective observational studies on semaglutide and tirzepatide in brand-name and compounded formulations. According to those data, the average total body weight loss was 27% with tirzepatide and 22% with semaglutide. The company clarifies that these are not randomized controlled trials and that individual results may vary. In its presentation, the company states that it has served more than 470,000 patients, has nearly 100 certified providers, and has received a rating of 4.9 out of 5 based on more than 39,000 reviews. It also mentions having been ranked 38th in the United States in the category of best GLP-1 care for 2026-2027.

Origin and Founding Team

Ivím Health was founded by Dr. Taylor Kantor, his brother Anthony Kantor, and Anthony's wife Kelly. The company emerged with the goal of reimagining cardiometabolic healthcare from a more accessible, individualized, and data-driven approach. Anthony Kantor serves as founder and chief executive officer; Dr. Taylor Kantor, a cardiac surgeon, is founder and chief innovation officer; and Dr. Jessica Duncan, a board-certified obesity medicine specialist, is the chief medical officer. The company also highlights that Dr. Duncan testified before the FDA to advocate for access to peptide therapies.

Presence and Coverage

Ivím Health operates as a virtual care platform, so its model does not depend on physical offices. The company states that it will notify patients of the availability of new therapies based on their state of residence, suggesting coverage subject to state regulation. Its offering is complemented by a corporate program and a resource center with a blog and press releases.